Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS: PLSH · Delayed Price · USD
0.158
-0.031 (-16.19%)
May 3, 2024, 3:41 PM EDT - Market closed
PLSH Revenue
In the year 2023, Panacea Life Sciences Holdings had annual revenue of $2.38M with 46.59% growth. Revenue in the quarter ending December 31, 2023 was $960.50K with 195.73% year-over-year growth.
Revenue (ttm)
$2.38M
Revenue Growth
+46.59%
P/S Ratio
1.17
Revenue / Employee
$125,524
Employees
19
Market Cap
2.80M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.38M | 757.98K | 46.59% |
Dec 31, 2022 | 1.63M | -432.65K | -21.01% |
Dec 31, 2021 | 2.06M | -6.96M | -77.16% |
Dec 31, 2020 | 9.02M | 8.67M | 2,508.69% |
Dec 31, 2019 | 345.68K | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 213.00 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
PLSH News
- 7 months ago - Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area - GlobeNewsWire
- 7 months ago - Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise - GlobeNewsWire
- 9 months ago - Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs - GlobeNewsWire
- 9 months ago - Panacea Life Sciences Holdings, Inc. Continues Pursuit of High Growth Health and Wellness Products with Acquisition of Sierra Sage, LLC and Halucenex from Melodial Global Health (formerly Creso Pharma Limited) - GlobeNewsWire
- 10 months ago - Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms - GlobeNewsWire
- 10 months ago - Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast - Accesswire
- 10 months ago - Panacea Life Sciences Holdings, Inc. Enters Into Agreement to Natural Health and Wellness Chain of Retail Locations in Tampa, Florida - GlobeNewsWire
- 10 months ago - Panacea Life Sciences Holdings, Inc. Adopts Diversification Plan: Vegan, Organic, Nutraceuticals, Alternative Health and Wellness Products and Investigative Research Plans for Psylocibin and other Psychedelics. - GlobeNewsWire